NE3107

Drug identity checked against registry records

Also recorded as bezisterim

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 3 Study of NE3107 in Probable Alzheimer's DiseaseNCT04669028BIVIPhase 3Completed2023-09-30Actual
A Study of NE3107 in Early Parkinson'sNCT06757010BIVIPhase 2Completed2026-05-01Actual
NE3107 in Adults With Neurological Symptoms of Long COVIDNCT06847191BIVIPhase 2Completed2026-08-06Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.